Literature DB >> 16571643

Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1.

M Lammert1, J M Friedman, H J Roth, R E Friedrich, L Kluwe, D Atkins, T Schooler, V-F Mautner.   

Abstract

Neurofibromatosis 1 (NF1) is a tumour suppressor gene syndrome characterized by multiple cutaneous and plexiform neurofibromas. Focal osseous abnormalities, short stature, and decreased bone mineral density are also frequent in people with NF1. We measured serum 25-hydroxyvitamin D concentrations in 55 patients with NF1 and 58 healthy controls, and correlated the findings in the patients with NF1 with their estimated number of dermal neurofibromas. Geometric mean (SD) serum 25-hydroxyvitamin D concentration was 14.0 (1.6) ng/mL among the patients with NF1 compared with 31.4 (1.7) ng/mL among healthy controls (p<<0.0001). The serum vitamin D concentration and number of dermal neurofibromas reported by patients with NF1 were inversely correlated (Spearman's rho = -0.572, p<0.00001). The occurrence of low serum vitamin D concentrations in people with NF1, especially those with many dermal neurofibromas, may provide new pathogenic insights and have important therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571643      PMCID: PMC2563168          DOI: 10.1136/jmg.2006.041095

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

Review 1.  NF1 tumor suppressor gene function: narrowing the GAP.

Authors:  K Cichowski; T Jacks
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use.

Authors:  Mona S Calvo; Susan J Whiting
Journal:  Nutr Rev       Date:  2003-03       Impact factor: 7.110

Review 3.  Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers.

Authors:  Michael F Holick
Journal:  South Med J       Date:  2005-10       Impact factor: 0.954

4.  Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities.

Authors:  T Illés; V Halmai; T de Jonge; J Dubousset
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

5.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

6.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

Review 7.  Studies of the effects of 1,25-dihydroxyvitamin D on skeletal and calcium homeostasis and on inhibition of tumor cell growth.

Authors:  D Goltzman; J White; R Kremer
Journal:  J Steroid Biochem Mol Biol       Date:  2001 Jan-Mar       Impact factor: 4.292

8.  Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.

Authors:  S A Rasmussen; Q Yang; J M Friedman
Journal:  Am J Hum Genet       Date:  2001-03-28       Impact factor: 11.025

Review 9.  Neurofibromatosis 1: closing the GAP between mice and men.

Authors:  Biplab Dasgupta; David H Gutmann
Journal:  Curr Opin Genet Dev       Date:  2003-02       Impact factor: 5.578

10.  NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.

Authors:  Tommi Kuorilehto; Marja Nissinen; Jussi Koivunen; M Douglas Benson; Juha Peltonen
Journal:  J Bone Miner Res       Date:  2004-01-27       Impact factor: 6.741

View more
  20 in total

1.  Perioperative management of neurofibromatosis type 1.

Authors:  Charles J Fox; Samir Tomajian; Aaron J Kaye; Stephanie Russo; Jacqueline Volpi Abadie; Alan D Kaye
Journal:  Ochsner J       Date:  2012

Review 2.  Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

Authors:  Qing Xiong; Yan Jiao; Karen A Hasty; S Terry Canale; John M Stuart; Wesley G Beamer; Hong-Wen Deng; David Baylink; Weikuan Gu
Journal:  Genomics       Date:  2009-01-14       Impact factor: 5.736

3.  Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1.

Authors:  David A Stevenson; David H Viskochil; John C Carey; Xiaoming Sheng; Mary Murray; Laurie Moyer-Mileur; Judd Shelton; William L Roberts; Ashley M Bunker; Heather Hanson; Stephanie Bauer; Jacques L D'Astous
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

4.  Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature.

Authors:  Digant Gupta; Pankaj G Vashi; Kristen Trukova; Christopher G Lis; Carolyn A Lammersfeld
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

5.  Bone mineral density in children and adolescents with neurofibromatosis type 1.

Authors:  David A Stevenson; Laurie J Moyer-Mileur; Mary Murray; Hillarie Slater; Xiaoming Sheng; John C Carey; Bukhosi Dube; David H Viskochil
Journal:  J Pediatr       Date:  2007-01       Impact factor: 4.406

6.  Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in France.

Authors:  Maud Jalabert; Salah Ferkal; Jean-Claude Souberbielle; Emilie Sbidian; Arthur Mageau; Florent Eymard; Philippe Le Corvoisier; Laurence Allanore; Xavier Chevalier; Pierre Wolkenstein; Sandra Guignard
Journal:  Calcif Tissue Int       Date:  2021-02-08       Impact factor: 4.333

Review 7.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

8.  Bone mineral density in children and young adults with neurofibromatosis type 1.

Authors:  Maya B Lodish; Urania Dagalakis; Ninet Sinaii; Ethan Bornstein; Aerang Kim; Kelsey B Lokie; Andrea M Baldwin; James C Reynolds; Eva Dombi; Constantine A Stratakis; Brigitte C Widemann
Journal:  Endocr Relat Cancer       Date:  2012-11-19       Impact factor: 5.678

9.  High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1.

Authors:  S Seitz; C Schnabel; B Busse; H U Schmidt; F T Beil; R E Friedrich; T Schinke; V F Mautner; M Amling
Journal:  Osteoporos Int       Date:  2009-05-05       Impact factor: 4.507

10.  Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Douglas R Stewart; Bruce R Korf; Katherine L Nathanson; David A Stevenson; Kaleb Yohay
Journal:  Genet Med       Date:  2018-04-26       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.